Table of Contents
Journal of Allergy
Volume 2012 (2012), Article ID 696792, 11 pages
http://dx.doi.org/10.1155/2012/696792
Research Article

Exhaled Eicosanoids following Bronchial Aspirin Challenge in Asthma Patients with and without Aspirin Hypersensitivity: The Pilot Study

Department of Medicine, Medical College, Jagiellonian University, ul. Skawińska 8, 31–066 Kraków, Poland

Received 13 July 2011; Accepted 30 September 2011

Academic Editor: A. P. Sampson

Copyright © 2012 L. Mastalerz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Horváth, J. Hunt, P. J. Barnes et al., “ATS/ERS task force on exhaled breath condensate: methodological recommendations and unresolved questions,” European Respiratory Journal, vol. 26, no. 3, pp. 523–548, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Montuschi, “Exhaled breath condensate: 8-isoprostane and eicosanoids,” in European Respiratory Monograph: Exhaled Biomarkers, I. Horvath and J. C. de Jongste, Eds., pp. 196–206, ERS, 2010. View at Google Scholar
  3. M. Sanak, A. Gielicz, K. Nagraba, M. Kaszuba, J. Kumik, and A. Szczeklik, “Targeted eicosanoids lipidomics of exhaled breath condensate in healthy subjects,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 878, no. 21, pp. 1796–1800, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Szczeklik, E. Niżankowska-Mogilnicka, and M. Sanak, “Hypersensitivity to aspirin and nonsteroidal anti-inflammatory drugs,” in Middleton's Allergy, N. F. Adkinson Jr., W. W. Busse, B. S. Bochner, S. T. Holgate, R. Lemanske, and F. E. R. Simons, Eds., pp. 1227–1243, Mosby, St. Louis, Mo, USA, 7th edition, 2009. View at Google Scholar
  5. A. Szczeklik, “The cyclooxygenase theory of aspirin-induced asthma,” European Respiratory Journal, vol. 3, no. 5, pp. 588–593, 1990. View at Google Scholar · View at Scopus
  6. A. Szczeklik and M. Sanak, “The broken balance in aspirin hypersensitivity,” European Journal of Pharmacology, vol. 533, no. 1–3, pp. 145–155, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. S. E. Wenzel, “Asthma: defining of the persistent adult phenotypes,” Lancet, vol. 368, no. 9537, pp. 804–813, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Higashi, H. Mita, E. Ono et al., “Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers,” Journal of Allergy and Clinical Immunology, vol. 125, no. 5, pp. 1084–1091, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. P. E. Christie, P. Tagari, A. W. Ford-Hutchinson et al., “Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects,” American Review of Respiratory Disease, vol. 143, no. 5 I, pp. 1025–1029, 1991. View at Google Scholar · View at Scopus
  10. M. Kumlin, B. Dahlén, T. Björck, O. Zetterström, E. Granström, and S.-E. Dahlén, “Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics,” American Review of Respiratory Disease, vol. 146, no. 1, pp. 96–103, 1992. View at Google Scholar · View at Scopus
  11. D. Schäfer, M. Schmid, U. C. Göde, and H. W. Baenkler, “Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics,” European Respiratory Journal, vol. 13, no. 3, pp. 638–646, 1999. View at Google Scholar · View at Scopus
  12. M. L. Kowalski, R. Pawlicźak, J. Wozniak et al., “Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 2 I, pp. 391–398, 2000. View at Google Scholar · View at Scopus
  13. C. A. Pérez-Novo, J. B. Watelet, C. Claeys, P. van Cauwenberge, and C. Bachert, “Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis,” Journal of Allergy and Clinical Immunology, vol. 115, no. 6, pp. 1189–1196, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Pierzchalska, Z. Szabo, M. Sanak, J. Soja, and A. Szczeklik, “Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma,” Journal of Allergy and Clinical Immunology, vol. 111, no. 5, pp. 1041–1048, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Ying, Q. Meng, G. Scadding, A. Parikh, C. J. Corrigan, and T. H. Lee, “Aspirin sensitive rhinosinusitis is associated with reduce E-prostanoid 2 (EP2) receptor expression on nasal mucosal inflammatory cells,” Journal of Allergy and Clinical Immunology, vol. 117, no. 2, pp. 312–318, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Jinnai, T. Sakagami, T. Sekigawa et al., “Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach,” Human Molecular Genetics, vol. 13, no. 24, pp. 3203–3217, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Mastalerz, M. Sanak, A. Gawlewicz-Mroczka et al., “Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity,” Thorax, vol. 63, no. 1, pp. 27–34, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Szczeklik, R. Dworski, L. Mastalerz et al., “Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism,” American Journal of Respiratory and Critical Care Medicine, vol. 158, no. 4, pp. 1168–1172, 1998. View at Google Scholar · View at Scopus
  19. F. Gaber, K. Daham, A. Higashi et al., “Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma,” Thorax, vol. 63, no. 12, pp. 1076–1082, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Bochenek, K. Nagraba, E. Nizankowska, and A. Szczeklik, “A controlled study of 9α1β-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge,” Journal of Allergy and Clinical Immunology, vol. 111, no. 4, pp. 743–749, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Higashi, M. Taniguchi, H. Mita, M. Osame, and K. Akiyama, “A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma,” Clinical and Experimental Allergy, vol. 32, no. 10, pp. 1484–1490, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. N. R. Ferreri, W. C. Howland, D. D. Stevenson, and H. L. Spiegelberg, “Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin,” American Review of Respiratory Disease, vol. 137, no. 4, pp. 847–854, 1988. View at Google Scholar · View at Scopus
  23. M. L. Kowalski, “Aspirin-sensitive rhinosinusitis and asthma,” Clinical Allergy and Immunology, vol. 19, pp. 147–175, 2007. View at Google Scholar · View at Scopus
  24. A. Szczeklik, K. Sladek, R. Dworski et al., “Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 6, pp. 1608–1614, 1996. View at Google Scholar · View at Scopus
  25. L. Mastalerz, M. Sanak, A. Gawlewicz, A. Gielicz, J. Faber, and A. Szczeklik, “Different eicosanoid profile of the hypersensitivity reactions triggered by aspirin and celecoxib in a patient with sinusitis, asthma, and urticaria,” Journal of Allergy and Clinical Immunology, vol. 118, no. 4, pp. 957–958, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Antczak, P. Montuschi, S. Kharitonov, P. Gorski, and P. J. Barnes, “Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 3, pp. 301–306, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Sanak, A. Gielicz, G. Bochenek et al., “Targeted eicosanoid lipidomics of exhaled breath condensate provide a distinct pattern in the aspirin-intolerant asthma phenotype,” Journal of Allergy and Clinical Immunology, vol. 127, pp. 1141–1147, 2011. View at Google Scholar
  28. M. Sanak, B. Kiełbasa, G. Bochenek, and A. Szczeklik, “Exhaled eicosanoids following oral aspirin challenge in asthmatic patients,” Clinical and Experimental Allergy, vol. 34, no. 12, pp. 1899–1904, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Niżankowska-Mogilnicka, G. Bochenek, L. Mastalerz et al., “EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity,” Allergy, vol. 62, no. 10, pp. 1111–1118, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. R. C. Murphy, R. M. Barkley, K. Z. Berry et al., “Electrospray ionization and tandem mass spectrometry of eicosanoids,” Analytical Biochemistry, vol. 346, no. 1, pp. 1–42, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Tsikas, “Application of gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry to assess in vivo synthesis of prostaglandins,thromboxane, leukotrienes, isoprostanes and related compounds in humans,” Journal of Chromatography B: Biomedical Sciences and Applications, vol. 717, pp. 201–245, 1998. View at Google Scholar
  32. H. Dressel, F. Muller, R. Fischer et al., “Independentinformation of nonspecific biomarkers in exhaled breath condensate,” Respiration, vol. 80, pp. 401–409, 2010. View at Google Scholar
  33. J. B. McCafferty, T. A. Bradshaw, S. Tate, A. P. Greening, and J. A. Innes, “Effects of breathing pattern and inspired air conditions on breath condensate volume, pH, nitrite, and protein concentrations,” Thorax, vol. 59, no. 8, pp. 694–698, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Schwarz, H. Biller, H. Windt, W. Koch, and J. M. Hohlfeld, “Characterization of exhaled particles from the healthy human lung—a systematic analysis in relation to pulmonary function variables,” Journal of Aerosol Medicine and Pulmonary Drug Delivery, vol. 23, no. 6, pp. 371–379, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. M. L. Kowalski, A. Ptasinska, M. Jedrzejczak et al., “Aspirin-triggered 15-HETE generation in peripheral blood leukocytes is a specific and sensitive aspirin-sensitive patients identification test (ASPITest),” Allergy, vol. 60, no. 9, pp. 1139–1145, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. M. L. Kowalski, A. Ptasińska, B. Bienkiewicz, R. Pawliczak, and L. DuBuske, “Differential effects of aspirin and misoprostol on 15-hydroxyeicosatetraenoic acid generation by leukocytes from aspirin-sensitive asthmatic patients,” Journal of Allergy and Clinical Immunology, vol. 112, no. 3, pp. 505–512, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. M. L. Kowalski, M. Borowiec, M. Kurowski, and R. Pawliczak, “Alternative splicing of cyclooxygenase-1 gene: altered expression in leucocytes from patients with bronchial asthma and association with aspirin-induced 15-HETE release,” Allergy, vol. 62, no. 6, pp. 628–634, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. A. R. Brash, W. E. Boeglin, and M. S. Chang, “Discovery of a second 15S-lipoxygenase in humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 12, pp. 6148–6152, 1997. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Sanak, M. Pierzchalska, S. Bazan-Socha, and A. Szczeklik, “Enhanced expression of the leukotriene C4 synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma,” American Journal of Respiratory Cell and Molecular Biology, vol. 23, no. 3, pp. 290–296, 2000. View at Google Scholar · View at Scopus
  40. C. Jenkins, J. Costello, and L. Hodge, “Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice,” British Medical Journal, vol. 328, no. 7437, pp. 434–437, 2004. View at Google Scholar · View at Scopus
  41. C. Sachs-Olsen, M. Sanak, A. M. Lang et al., “Eoxins: a new inflammatory pathway in childhood asthma,” Journal of Allergy and Clinical Immunology, vol. 126, no. 4, pp. 859–867, 2010. View at Publisher · View at Google Scholar · View at Scopus